Lingbing Li

1.0k total citations
34 papers, 867 citations indexed

About

Lingbing Li is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Lingbing Li has authored 34 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomaterials, 11 papers in Pharmaceutical Science and 10 papers in Molecular Biology. Recurrent topics in Lingbing Li's work include Nanoparticle-Based Drug Delivery (24 papers), Advanced Drug Delivery Systems (11 papers) and Drug Transport and Resistance Mechanisms (8 papers). Lingbing Li is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), Advanced Drug Delivery Systems (11 papers) and Drug Transport and Resistance Mechanisms (8 papers). Lingbing Li collaborates with scholars based in China and Hong Kong. Lingbing Li's co-authors include Yakun Ma, Xiaohui Fan, Guangxi Zhai, Wei Xu, Yanli Zhao, Jianbo Ji, Na Li, Xuling Chen, Yixin Zhu and Yingjie Zhai and has published in prestigious journals such as Journal of Colloid and Interface Science, Carbohydrate Polymers and International Journal of Pharmaceutics.

In The Last Decade

Lingbing Li

34 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingbing Li China 18 456 281 258 196 123 34 867
Junguo Hao China 8 492 1.1× 333 1.2× 212 0.8× 203 1.0× 166 1.3× 9 870
Tianyang Ren China 17 343 0.8× 268 1.0× 213 0.8× 270 1.4× 77 0.6× 26 857
Supriya Shidhaye India 12 495 1.1× 306 1.1× 232 0.9× 477 2.4× 166 1.3× 29 1.2k
Sri Vishnu Kiran Rompicharla India 18 325 0.7× 339 1.2× 223 0.9× 147 0.8× 72 0.6× 25 821
Xiaomeng Wan China 10 386 0.8× 194 0.7× 194 0.8× 76 0.4× 183 1.5× 14 700
Leilei Hao China 15 376 0.8× 307 1.1× 134 0.5× 265 1.4× 65 0.5× 23 794
XiaWei Wei China 11 570 1.3× 253 0.9× 432 1.7× 156 0.8× 187 1.5× 12 1.1k
Fakhara Sabir Hungary 19 323 0.7× 340 1.2× 300 1.2× 281 1.4× 64 0.5× 24 1.1k

Countries citing papers authored by Lingbing Li

Since Specialization
Citations

This map shows the geographic impact of Lingbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingbing Li more than expected).

Fields of papers citing papers by Lingbing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingbing Li. The network helps show where Lingbing Li may publish in the future.

Co-authorship network of co-authors of Lingbing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lingbing Li. A scholar is included among the top collaborators of Lingbing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingbing Li. Lingbing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Ke, et al.. (2024). Human serum albumin and sialic acid co-modified liposome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy. Journal of Drug Delivery Science and Technology. 92. 105343–105343. 2 indexed citations
2.
Jiang, Wenxi, Ruiqing Chen, Lingbing Li, et al.. (2024). Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study. Journal of Cancer Research and Clinical Oncology. 150(9). 1 indexed citations
6.
Chen, Xuling, et al.. (2020). Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel. Carbohydrate Polymers. 255. 117393–117393. 45 indexed citations
7.
Zhu, Yixin, Yakun Ma, Yanli Zhao, Min Yang, & Lingbing Li. (2018). Preparation and evaluation of highly biocompatible nanogels with pH-sensitive charge-convertible capability based on doxorubicin prodrug. Materials Science and Engineering C. 98. 161–176. 8 indexed citations
8.
Yang, Min, et al.. (2018). Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs. Colloids and Surfaces B Biointerfaces. 175. 126–135. 35 indexed citations
9.
Ma, Yakun, et al.. (2016). Advancement of multifunctional hybrid nanogel systems: Construction and application in drug co-delivery and imaging technique. Materials Science and Engineering C. 71. 1281–1292. 37 indexed citations
10.
Fan, Xiaohui, Yanli Zhao, Wei Xu, & Lingbing Li. (2016). Linear–dendritic block copolymer for drug and gene delivery. Materials Science and Engineering C. 62. 943–959. 47 indexed citations
11.
Xu, Wei, Xiaohui Fan, Yanli Zhao, & Lingbing Li. (2015). Cysteine modified and bile salt based micelles: Preparation and application as an oral delivery system for paclitaxel. Colloids and Surfaces B Biointerfaces. 128. 165–171. 18 indexed citations
12.
Jiao, Yan, Xin Pang, Mengrui Liu, et al.. (2015). Recent progresses in bioadhesive microspheres via transmucosal administration. Colloids and Surfaces B Biointerfaces. 140. 361–372. 23 indexed citations
13.
Zhou, Yi, et al.. (2014). Folate-modified pluronic-polyethylenimine and cholic acid polyion complex micelles as targeted drug delivery system for paclitaxel. Journal of Microencapsulation. 31(8). 805–814. 13 indexed citations
14.
Pei, Wei, et al.. (2011). Pharmacokinetic analysis and optimization of hydroxycamptothecin-loaded nanoparticles for liver targeting. Drug Development and Industrial Pharmacy. 38(7). 837–847. 8 indexed citations
15.
Li, Na, et al.. (2010). Novel nanogels as drug delivery systems for poorly soluble anticancer drugs. Colloids and Surfaces B Biointerfaces. 83(2). 237–244. 52 indexed citations
16.
Li, Lingbing, et al.. (2009). Mixed micelles made of Pluronic P105 and L61 as pharmaceutical nanocarriers for camptothecin. Journal of Shandong University. 47(11). 128–131. 1 indexed citations
17.
Li, Lingbing. (2008). Studies on Preparation of Quercetin Solid Lipid Nanoparticles and Oral Absorption in Mice. Zhōnghuá yàoxué zázhì. 1 indexed citations
18.
Li, Lingbing, et al.. (2008). Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers. International Journal of Pharmaceutics. 370(1-2). 210–215. 27 indexed citations
19.
Li, Lingbing, et al.. (2007). Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE. Journal of Colloid and Interface Science. 317(1). 326–331. 60 indexed citations
20.
Li, Lingbing, et al.. (2004). [Synthesis and the drug release properties of poly(acrylamide-co-glycosylallylamide) hydrogels].. PubMed. 21(6). 960–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026